急性リンパ性白血病治療の世界市場 2020年：企業別、地域別、種類・用途別

• レポートコード： • 出版社/出版日： / • レポート形態：、、ページ数はお問い合わせください。 • 納品方法：

• 販売価格（消費税別）

￥ 日本円の価格はお問い合わせください。 (0)

▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Market Overview
The Acute Lymphoid Leukemia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Acute Lymphoid Leukemia Treatment sales will be xx in 2020 from Acute Lymphoid Leukemia Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Acute Lymphoid Leukemia Treatment market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Acute Lymphoid Leukemia Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Acute Lymphoid Leukemia Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Acute Lymphoid Leukemia Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Acute Lymphoid Leukemia Treatment market has been segmented into:
Chemotherapy
Targeted Therapy
Radiation Therapy
Bone Marrow Transplant
Immunotherapy
Others

By Application, Acute Lymphoid Leukemia Treatment has been segmented into:
Adults
Children

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acute Lymphoid Leukemia Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Acute Lymphoid Leukemia Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acute Lymphoid Leukemia Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Acute Lymphoid Leukemia Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Acute Lymphoid Leukemia Treatment Market Share Analysis
Acute Lymphoid Leukemia Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acute Lymphoid Leukemia Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acute Lymphoid Leukemia Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Acute Lymphoid Leukemia Treatment are:
Amgen
Novartis
Pfizer
Bristol-Myers Squibb
Rare Disease Therapeutics
Genzyme
Takeda （ARIAD）
ERYtech Pharma
GlaxoSmithKline
Sanofi
Spectrum Pharmaceuticals
Exelead (Essetifin)
Ziopharm Oncology

レポート目次

---

1 Acute Lymphoid Leukemia Treatment Market Overview
1.1 Product Overview and Scope of Acute Lymphoid Leukemia Treatment
1.2 Classification of Acute Lymphoid Leukemia Treatment by Type
1.2.1 Global Acute Lymphoid Leukemia Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acute Lymphoid Leukemia Treatment Revenue Market Share by Type in 2019
1.2.3 Chemotherapy
1.2.4 Targeted Therapy
1.2.5 Radiation Therapy
1.2.6 Bone Marrow Transplant
1.2.7 Immunotherapy
1.2.8 Others
1.3 Global Acute Lymphoid Leukemia Treatment Market by Application
1.3.1 Overview: Global Acute Lymphoid Leukemia Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Children
1.4 Global Acute Lymphoid Leukemia Treatment Market by Regions
1.4.1 Global Acute Lymphoid Leukemia Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acute Lymphoid Leukemia Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acute Lymphoid Leukemia Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acute Lymphoid Leukemia Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Lymphoid Leukemia Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acute Lymphoid Leukemia Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Lymphoid Leukemia Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Acute Lymphoid Leukemia Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the Acute Lymphoid Leukemia Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Acute Lymphoid Leukemia Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb SWOT Analysis
2.4.4 Bristol-Myers Squibb Product and Services
2.4.5 Bristol-Myers Squibb Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Rare Disease Therapeutics
2.5.1 Rare Disease Therapeutics Details
2.5.2 Rare Disease Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Rare Disease Therapeutics SWOT Analysis
2.5.4 Rare Disease Therapeutics Product and Services
2.5.5 Rare Disease Therapeutics Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Genzyme
2.6.1 Genzyme Details
2.6.2 Genzyme Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Genzyme SWOT Analysis
2.6.4 Genzyme Product and Services
2.6.5 Genzyme Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda （ARIAD）
2.7.1 Takeda （ARIAD） Details
2.7.2 Takeda （ARIAD） Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Takeda （ARIAD） SWOT Analysis
2.7.4 Takeda （ARIAD） Product and Services
2.7.5 Takeda （ARIAD） Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 ERYtech Pharma
2.8.1 ERYtech Pharma Details
2.8.2 ERYtech Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ERYtech Pharma SWOT Analysis
2.8.4 ERYtech Pharma Product and Services
2.8.5 ERYtech Pharma Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanofi SWOT Analysis
2.10.4 Sanofi Product and Services
2.10.5 Sanofi Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Spectrum Pharmaceuticals
2.11.1 Spectrum Pharmaceuticals Details
2.11.2 Spectrum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Spectrum Pharmaceuticals SWOT Analysis
2.11.4 Spectrum Pharmaceuticals Product and Services
2.11.5 Spectrum Pharmaceuticals Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Exelead (Essetifin)
2.12.1 Exelead (Essetifin) Details
2.12.2 Exelead (Essetifin) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Exelead (Essetifin) SWOT Analysis
2.12.4 Exelead (Essetifin) Product and Services
2.12.5 Exelead (Essetifin) Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ziopharm Oncology
2.13.1 Ziopharm Oncology Details
2.13.2 Ziopharm Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ziopharm Oncology SWOT Analysis
2.13.4 Ziopharm Oncology Product and Services
2.13.5 Ziopharm Oncology Acute Lymphoid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acute Lymphoid Leukemia Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Lymphoid Leukemia Treatment Players Market Share
3.2.2 Top 10 Acute Lymphoid Leukemia Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acute Lymphoid Leukemia Treatment Revenue and Market Share by Regions
4.2 North America Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
5 North America Acute Lymphoid Leukemia Treatment Revenue by Countries
5.1 North America Acute Lymphoid Leukemia Treatment Revenue by Countries (2015-2020)
5.2 USA Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6 Europe Acute Lymphoid Leukemia Treatment Revenue by Countries
6.1 Europe Acute Lymphoid Leukemia Treatment Revenue by Countries (2015-2020)
6.2 Germany Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6.4 France Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acute Lymphoid Leukemia Treatment Revenue by Countries
7.1 Asia-Pacific Acute Lymphoid Leukemia Treatment Revenue by Countries (2015-2020)
7.2 China Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7.5 India Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
8 South America Acute Lymphoid Leukemia Treatment Revenue by Countries
8.1 South America Acute Lymphoid Leukemia Treatment Revenue by Countries (2015-2020)
8.2 Brazil Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acute Lymphoid Leukemia Treatment by Countries
9.1 Middle East & Africa Acute Lymphoid Leukemia Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Acute Lymphoid Leukemia Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acute Lymphoid Leukemia Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Acute Lymphoid Leukemia Treatment Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Targeted Therapy Revenue Growth Rate (2015-2025)
10.5 Radiation Therapy Revenue Growth Rate (2015-2025)
10.6 Bone Marrow Transplant Revenue Growth Rate (2015-2025)
10.7 Immunotherapy Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Acute Lymphoid Leukemia Treatment Market Segment by Application
11.1 Global Acute Lymphoid Leukemia Treatment Revenue Market Share by Application (2015-2020)
11.2 Acute Lymphoid Leukemia Treatment Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2015-2020)
11.4 Children Revenue Growth (2015-2020)
12 Global Acute Lymphoid Leukemia Treatment Market Size Forecast (2021-2025)
12.1 Global Acute Lymphoid Leukemia Treatment Market Size Forecast (2021-2025)
12.2 Global Acute Lymphoid Leukemia Treatment Market Forecast by Regions (2021-2025)
12.3 North America Acute Lymphoid Leukemia Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Acute Lymphoid Leukemia Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acute Lymphoid Leukemia Treatment Revenue Market Forecast (2021-2025)
12.6 South America Acute Lymphoid Leukemia Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acute Lymphoid Leukemia Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

---